Texas A&M And University Of Minnesota Researchers Receive $3.8M To Develop New Mpox Treatment
Researchers at the Texas A&M College of Veterinary Medicine & Biomedical Sciences (VMBS) and the University of Minnesota have received a $3.8 million grant from the National Institutes of Health (NIH) to develop antiviral drugs for treating mpox — formerly known as monkeypox — a disease that creates a noticeable rash and blisters. Mpox made headlines […]
Is Smallpox Still A Threat Worth Preparing For? Report with Texas A&M Scientist Contribution Says Yes
Smallpox, a disease that killed an estimated 500 million people in the 20th century alone, is the only human disease to be eradicated. However, a new report, Future State of Smallpox Medical Countermeasures, from the National Academies of Science, Engineering, and Medicine (NASEM) argues that the U.S. and the global community should prepare for smallpox […]
VMBS Researcher Developing New Antiviral Drugs For Mpox, Methods For Fighting Future Pandemics
In 2020, the world was abuzz with the shocking news of the COVID-19 pandemic’s outbreak. In most people’s minds, large-scale pandemics were not a feature of the modern world but rather a problem of the past, like the Black Death that wiped out somewhere between one- to two-thirds of Europe’s population in the Late Middle […]
